Hans Boesmueller

Summary

Affiliation: Krankenhaus Barmherzige Schwestern
Country: Austria

Publications

  1. doi [Mitosis in early invasive malignant melanoma. How reliable is histogenetic classification at stage pT1?]
    H Bösmüller
    Institut fur Pathologie, Krankenhaus der Barmherzigen Schwestern Linz, Seilerstätte 4, 4020, Linz, Osterreich
    Pathologe 33:113-7. 2012
  2. doi Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR
    Hans Bösmüller
    Department of Pathology, Krankenhaus Barmherzige Schwestern Linz, Austria
    Hum Pathol 44:329-35. 2013
  3. pmc Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia
    Johanna M Kralik
    Laboratory of Molecular Biology and Tumorcytogenetics, Department of Internal Medicine I, Krankenhaus der Barmherzigen Schwestern, Seilerstaette 4, 4010 Linz, Austria
    Diagn Pathol 6:19. 2011
  4. doi Paratesticular fibrous pseudotumor--an IgG4-related disorder?
    Hans Bösmüller
    Department of Pathology, Krankenhaus Barmherzige Schwestern, Seilerstätte 4, 4020, Linz, Austria
    Virchows Arch 458:109-13. 2011
  5. pmc Lymphoepithelioma-like carcinoma of the vulva, an underrecognized entity? Case report with a single inguinal micrometastasis detected by sentinel node technique
    Hans Bösmüller
    Department of Pathology, Krankenhaus Barmherzige Schwestern, Linz, Austria
    Diagn Pathol 6:4. 2011
  6. doi Morphological and molecular heterogeneity in colorectal neoplasms with K-RAS mutation. A report of two cases
    Hans Bösmüller
    Institute of Pathology, Krankenhaus Barmherzige Schwestern Linz, Seilerstätte 4, A 4020 Linz, Austria
    Pathol Res Pract 207:399-402. 2011
  7. doi Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy
    Hans Bösmüller
    Department of Pathology, Krankenhaus Barmherzige Schwestern Linz, Seilerstätte 4, 4020, Linz, Austria
    Virchows Arch 459:183-91. 2011
  8. pmc Primary angiosarcoma of the ovary with prominent fibrosis of the ovarian stroma. Case report of an 81-year old patient
    Hans Bösmüller
    Department of Pathology, Krankenhaus Barmherzige Schwestern Linz, Austria
    Diagn Pathol 6:65. 2011
  9. doi SOX2 expression and prognostic significance in ovarian carcinoma
    Deborah L Pham
    Institute of Pathology, University of Tuebingen, Tuebingen, Germany
    Int J Gynecol Pathol 32:358-67. 2013

Collaborators

  • Gerald Webersinke
  • Tanja Fehm
  • Claudia Lengerke
  • Hans Neubauer
  • T Hintringer
  • T Mentzel
  • Gregor Mikuz
  • Steffen Hauptmann
  • Patrick Adam
  • David Capper
  • Hans Bösmüller
  • Falko Fend
  • Deborah L Pham
  • Annette Staebler
  • Sophie Haitchi-Petnehazy
  • Anna Fischer
  • H Bösmüller
  • Irina Bonzheim
  • Renate Marschon
  • Wolfgang Stummvoll
  • Johanna M Kralik
  • Christine Gruber
  • Wolfgang Kranewitter
  • Franz Roithmeier
  • Holger Rumpold
  • Cornelia Bachmann
  • Sven Perner
  • Veit Scheble
  • Petra Bareiss
  • Annemarie Adam
  • Andreas von Deimling
  • Diethelm Wallwiener
  • Lothar Kanz
  • Christine Beschorner
  • S Haitchi-Petnehazy
  • Margit Klier-Richter
  • Dietmar Wagner
  • Margit Hackl
  • Kurt Wiesinger
  • Vedat Alibegovic
  • Claus Hann von Weyhern
  • Martin Erdel
  • Gertraud Tschurtschenthaler
  • Andreas L Petzer

Detail Information

Publications9

  1. doi [Mitosis in early invasive malignant melanoma. How reliable is histogenetic classification at stage pT1?]
    H Bösmüller
    Institut fur Pathologie, Krankenhaus der Barmherzigen Schwestern Linz, Seilerstätte 4, 4020, Linz, Osterreich
    Pathologe 33:113-7. 2012
    ..A level of reasonable doubt remains regarding the distinct histogenetic classification of mitosis as early stage melanoma with regard to their epithelial or melanocytic origin...
  2. doi Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR
    Hans Bösmüller
    Department of Pathology, Krankenhaus Barmherzige Schwestern Linz, Austria
    Hum Pathol 44:329-35. 2013
    ....
  3. pmc Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia
    Johanna M Kralik
    Laboratory of Molecular Biology and Tumorcytogenetics, Department of Internal Medicine I, Krankenhaus der Barmherzigen Schwestern, Seilerstaette 4, 4010 Linz, Austria
    Diagn Pathol 6:19. 2011
    ..We describe the characterization of a new ETV6 fusion gene in acute myeloid leukemia (AML) FAB M0 as a result of an uncommon translocation involving chromosomes 12 and 15...
  4. doi Paratesticular fibrous pseudotumor--an IgG4-related disorder?
    Hans Bösmüller
    Department of Pathology, Krankenhaus Barmherzige Schwestern, Seilerstätte 4, 4020, Linz, Austria
    Virchows Arch 458:109-13. 2011
    ....
  5. pmc Lymphoepithelioma-like carcinoma of the vulva, an underrecognized entity? Case report with a single inguinal micrometastasis detected by sentinel node technique
    Hans Bösmüller
    Department of Pathology, Krankenhaus Barmherzige Schwestern, Linz, Austria
    Diagn Pathol 6:4. 2011
    ....
  6. doi Morphological and molecular heterogeneity in colorectal neoplasms with K-RAS mutation. A report of two cases
    Hans Bösmüller
    Institute of Pathology, Krankenhaus Barmherzige Schwestern Linz, Seilerstätte 4, A 4020 Linz, Austria
    Pathol Res Pract 207:399-402. 2011
    ....
  7. doi Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy
    Hans Bösmüller
    Department of Pathology, Krankenhaus Barmherzige Schwestern Linz, Seilerstätte 4, 4020, Linz, Austria
    Virchows Arch 459:183-91. 2011
    ..In conclusion, the density of CD3+ and CD8+ T-cells in tumor stroma proved to be a significant predictor for response to platinum-based therapy, whereas examination of ERCC1 failed to identify therapy-responsive patients...
  8. pmc Primary angiosarcoma of the ovary with prominent fibrosis of the ovarian stroma. Case report of an 81-year old patient
    Hans Bösmüller
    Department of Pathology, Krankenhaus Barmherzige Schwestern Linz, Austria
    Diagn Pathol 6:65. 2011
    ..Most reports refer to younger individuals, aged from 7 to 46 years, and only 2 case reports could be found for patients older than 64 years. Here we present a very unusual case of angiosarcoma in a 81-year-old patient...
  9. doi SOX2 expression and prognostic significance in ovarian carcinoma
    Deborah L Pham
    Institute of Pathology, University of Tuebingen, Tuebingen, Germany
    Int J Gynecol Pathol 32:358-67. 2013
    ..21 mo, P=0.041; median overall survival 39 vs. 25 mo, P=0.062). Further studies are needed to explore whether expression of SOX2 has a specific role in prognosis and therapy response...